4//SEC Filing
Castle Jeremy 4
Accession 0001079973-25-000519
CIK 0001799191other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:33 PM ET
Size
8.7 KB
Accession
0001079973-25-000519
Insider Transaction Report
Form 4
Castle Jeremy
Chief Operating Officer
Transactions
- Purchase
Common Stock
2025-03-26$1.04/sh+9,056$9,434→ 90,386 total - Purchase
Common Warrant
2025-03-26$0.13/sh+4,528$566→ 4,528 totalExercise: $1.20From: 2025-03-26Exp: 2030-03-26→ Common Stock (4,528 underlying)
Footnotes (4)
- [F1]Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the "Private Placement"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock ("Common Stock") and a common warrant ("Common Warrant") to purchase one share of Common Stock (the "Private Placement Unit").
- [F2]The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- [F3]Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250.
- [F4]The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001992507
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 5:33 PM ET
- Size
- 8.7 KB